Skip Navigation
Skip to contents

JYMS : Journal of Yeungnam Medical Science

Indexed in: ESCI, Scopus, PubMed,
PubMed Central, CAS, DOAJ, KCI
FREE article processing charge
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Colchicine"
Filter
Filter
Article category
Keywords
Publication year
Authors
Case Reports
Colchicine for steroid-resistant recurrent pericarditis in a child
Ju Hee Shin, Dong Hyun Lee, Hee Joung Choi
Yeungnam Univ J Med. 2018;35(2):222-226.   Published online December 31, 2018
DOI: https://doi.org/10.12701/yujm.2018.35.2.222
  • 4,977 View
  • 82 Download
  • 3 Crossref
AbstractAbstract PDF
Recurrent pericarditis is rare in children and is considered idiopathic in most cases. Its course is chronic, and preventing recurrences is important for the patient’s quality of life. Although a treatment strategy in pediatric recurrent pericarditis has not yet been established, non-steroidal anti-inflammatory drugs (NSAIDs) are the most common treatment for management of this condition, followed by corticosteroids, colchicine, immunosuppressive agents, immunoglobulins, and interleukin-1β receptor antagonists (e.g. anakinra). Herein, we report a case of recurrent pericarditis with pericardial effusion in a 5-year-old child who presented with fever and epigastric pain. He responded poorly to NSAIDs and corticosteroid therapy, but was successfully treated with colchicine.

Citations

Citations to this article as recorded by  
  • Anakinra in idiopathic recurrent pericarditis: a comprehensive case series and literature review
    Zeynep Toker Dincer, Sejla Karup, Erkin Yilmaz, Osman Corbali, Feyza Nur Azman, Melike Melikoglu, Serdal Ugurlu
    Zeitschrift für Rheumatologie.2024;[Epub]     CrossRef
  • Pediatric Pericarditis: Update
    Rida Shahid, Justin Jin, Kyle Hope, Hari Tunuguntla, Shahnawaz Amdani
    Current Cardiology Reports.2023;[Epub]     CrossRef
  • Effects of Systemic Steroid Administration on Recurrence of Pericardial Effusion in Pediatric Patients After Hematopoietic Stem Cell Transplantation
    Kieran Leong, Martha E. Heal, John L. Bass, Varun Aggarwal, Shanti Narasimhan, Ashish Gupta, Gurumurthy Hiremath
    Journal of Pediatric Hematology/Oncology.2020; 42(4): 256.     CrossRef
A Case of Colchicine-Induced Neutropenia in Liver Cirrhosis Patient.
Ho Chan Lee, Heon Ju Lee, Yong Gil Kim, Jae Hyun Park, Sung Joon Kim, Jun Seok Park
Yeungnam Univ J Med. 2009;26(2):125-129.   Published online December 31, 2009
DOI: https://doi.org/10.12701/yujm.2009.26.2.125
  • 1,758 View
  • 4 Download
AbstractAbstract PDF
Colchicine is an alkaloid that has been used for treating acute gouty arthritis, psoriasis, scleroderma and Behcet's syndrome. Colchicine decreased liver fibrosis in rats with carbon tetrachloride induced cirrhosis and in patients with many liver diseases. Therapeutic oral doses of colchicine may cause nausea, vomiting, abdominal pain and diarrhea. The adverse effect of colchicine associated with the dose is bone marrow suppression, and especially neutopenia. Neutropenia has often been reported in patients have taken an overdose of colchicine. We describe a 64-year-old female liver cirrhosis patient with neutropenia that was induced by a therapeutic dose of colchicine.

JYMS : Journal of Yeungnam Medical Science